Sobi, which currently has a drug under FDA review as a later line of therapy for gout, is paying $950 million to acquire ...

For gout pain that does not respond to conventional therapies, patients’ only remaining option is a drug from Amgen. But this biologic medicine introduces the same problem facing every therapeutic ...

October 2, 2012 — New gout guidelines from the American College of Rheumatology are meant to improve gout management by providing clinicians with clear, readily implemented guidance on urate-lowering ...

WASHINGTON, DC — Use of sodium-glucose cotransporter-2 inhibitors (SGLT2i) reduced the need for urate-lowering therapy (ULT) and gout flare therapies in people who had both type 2 diabetes (T2D) and ...

In recent years, scientists have increasingly turned their attention to older, affordable drugs to explore whether they offer benefits beyond their original purpose. Colchicine, a cheap and widely ...

In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...

A widely available drug used for gout may help prevent heart attacks and stroke in people with cardiovascular disease. The corresponding review was published in the Cochrane Database of Systematic ...

The introduction of urate-lowering therapy can affect the risk for gout flares, with fewer flares observed when less intensive treatment and flare prophylaxis were used. The introduction of ...

Please provide your email address to receive an email when new articles are posted on . More than 25% of patients with gout who use colchicine prophylaxis were on potentially interacting medications.

BANGALORE (Reuters) - Regeneron Pharmaceuticals Inc said its experimental treatment to reduce gout flares, Arcalyst, met the main goal in a mid-stage trial and reduced flares by 81 percent, sending ...

A new study finds that TikTok videos about gout frequently spread confusing or inaccurate advice. Most clips focus on diet ...